{"schema_version":"secwatch.filing_event.v1","accession":"0001842952-24-000087","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2024-12-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.988338+00:00","generated_at":"2026-05-28T23:47:50.073620+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Context Therapeutics sells 14.7M shares for ~$15M to MPM BioImpact","bullets":["Sold 14,705,882 shares at ~$1.02/share for aggregate gross proceeds of ~$15M.","Shares purchased by MPM BioImpact LLC under sales agreement with Leerink Partners dated Dec 2, 2024.","Proceeds expected to fund working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001842952-24-000087","json":"https://secwatch.observer/filing/0001842952-24-000087.json","markdown":"https://secwatch.observer/filing/0001842952-24-000087.md","text":"https://secwatch.observer/filing/0001842952-24-000087.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000184295224000087/0001842952-24-000087-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000184295224000087/cntx-20241223.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T23:47:50.073620+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}